COVISHIELD
Commercial- Indications
- COVID-19
Company intelligence / Profile preview
Cyrus Poonawalla Group
Pune, Maharashtra, Indiacyruspoonawallagroup.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
The Serum Institute of India (SII), a key subsidiary, is the world's largest vaccine manufacturer by number of doses produced and sold globally (more than 1.5 billion doses). SII produced Covishield (AstraZeneca COVID-19 vaccine) with over 1 billion doses shipped globally. The company recently received European Commission Marketing Authorization for SIILTIBCY, a novel tuberculosis skin test in Europe.
- Therapeutic areas
- Infectious Diseases
- Modalities
- VaccinesImmunobiologicals
- Industry
- Pharma
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
AstraZeneca (for COVID-19 vaccine)Panchshil Realty
Beyond the preview
Go deeper on Cyrus Poonawalla Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cyrus Poonawalla Group.